Literature DB >> 16388504

T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction.

Jason R Lees1, Bridget Charbonneau, John D Hayball, Kerrilyn Diener, Michael Brown, Robert Matusik, Michael B Cohen, Timothy L Ratliff.   

Abstract

METHODS: The ability of CD8(+) T-cells to induce prostate inflammation was examined using a prostate ovalbumin expressing transgenic mouse (POET) and/or adoptive transfer of T-cell receptor (TCR) transgenic T-cells (OT-I) that specifically recognize ovalbumin. Localization of inflammatory cells to prostate tissue was examined following T-cell activation via endogenous prostatic antigen, recombinant type 5 adenovirus carrying the gene coding ovalbumin (Ad5-mOVA), or adoptive transfer of in vitro antigen stimulated OT-I cells.
RESULTS: Ovalbumin specific OT-I cells were activated by autologous prostate antigen and trafficked to the prostate, but did not induce inflammation unless present in overwhelming numbers ( approximately 65% of CD8(+) T-cells). Activation of antigen specific CD8(+) T-cells in vitro (peptide pulsed antigen presenting cells) or in vivo (Ad5-mOVA) induced transitory prostate inflammation, without induction of prostate pathology, regardless of CD4(+) T-cell availability. Inflammation also was observed in OT-I x POET mice but again, pathological effects were not observed.
CONCLUSIONS: T lymphocytes specific for a prostate antigen are capable of inducing inflammatory infiltration of prostatic tissue rapidly following activation, but do not produce pathological prostate injury. Prostate 66:578-590, 2006. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388504     DOI: 10.1002/pros.20307

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

1.  In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.

Authors:  Jessica M Haverkamp; Scott A Crist; Bennett D Elzey; Cansu Cimen; Timothy L Ratliff
Journal:  Eur J Immunol       Date:  2011-02-02       Impact factor: 5.532

2.  Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.

Authors:  Tullia C Bruno; Cristin Rothwell; Joseph F Grosso; Derese Getnet; Hung Rong Yen; Nicholas M Durham; George Netto; Drew M Pardoll; Charles G Drake
Journal:  Prostate       Date:  2011-07-14       Impact factor: 4.104

3.  An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.

Authors:  Jessica M Haverkamp; Bridget Charbonneau; Scott A Crist; David K Meyerholz; Michael B Cohen; Paul W Snyder; Robert U Svensson; Michael D Henry; Hsing-Hui Wang; Timothy L Ratliff
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

4.  α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma.

Authors:  David S Garlick; Jing Li; Brian Sansoucy; Tao Wang; Leeanne Griffith; Tj Fitzgerald; Julie Butterfield; Bridget Charbonneau; Shelia M Violette; Paul H Weinreb; Timothy L Ratliff; Chun-Peng Liao; Pradip Roy-Burman; Michele Vietri; Jane B Lian; Gary S Stein; Dario C Altieri; Lucia R Languino
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

5.  Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.

Authors:  Wujiang Liu; David P Evanoff; Xiaohong Chen; Yi Luo
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

6.  Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis.

Authors:  Grant N Burcham; Gregory M Cresswell; Paul W Snyder; Long Chen; Xiaoqi Liu; Scott A Crist; Michael D Henry; Timothy L Ratliff
Journal:  Am J Pathol       Date:  2014-11-22       Impact factor: 4.307

Review 7.  Prostate cancer as a model for tumour immunotherapy.

Authors:  Charles G Drake
Journal:  Nat Rev Immunol       Date:  2010-08       Impact factor: 53.106

8.  Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.

Authors:  Yi T Koh; Andrew Gray; Sean A Higgins; Bolyn Hubby; W Martin Kast
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

9.  Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.

Authors:  Cassie K Chou; Andrea Schietinger; H Denny Liggitt; Xiaoxia Tan; Sarah Funk; Gordon J Freeman; Timothy L Ratliff; Norman M Greenberg; Philip D Greenberg
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

10.  Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Authors:  Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; Robert Anders; Drew M Pardoll; Charles G Drake
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.